相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
Psychiatry & the psychedelic drugs. Past, present & future
James J. H. Rucker et al.
NEUROPHARMACOLOGY (2018)
Long-lasting subjective effects of LSD in normal subjects
Yasmin Schmid et al.
PSYCHOPHARMACOLOGY (2018)
Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination
O. Grimm et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Serotonergic psychedelics and personality: A systematic review of contemporary research
Jose Carlos Bouso et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
Simon Reiche et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
Altered network hub connectivity after acute LSD administration
Felix Mueller et al.
NEUROIMAGE-CLINICAL (2018)
Alterations of consciousness and mystical-type experiences after acute LSD in humans
Matthias E. Liechti et al.
PSYCHOPHARMACOLOGY (2017)
Modern Clinical Research on LSD
Matthias E. Liechti
NEUROPSYCHOPHARMACOLOGY (2017)
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Robin L. Carhart-Harris et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects
F. Mueller et al.
TRANSLATIONAL PSYCHIATRY (2017)
The Endless Trip among the nPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review
Laura Orsolini et al.
FRONTIERS IN PSYCHIATRY (2017)
Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations
F. Mueller et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller et al.
CURRENT BIOLOGY (2017)
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens
Jose Carlos Bouso et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2016)
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study
Rafael Faria Sanches et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging
Rafael G. dos Santos et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide
Jana Speth et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Classical hallucinogens and neuroimaging: A systematic review of human studies Hallucinogens and neuroimaging
Rafael G. dos Santos et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The paradoxical psychological effects of lysergic acid diethylamide (LSD)
R. L. Carhart-Harris et al.
PSYCHOLOGICAL MEDICINE (2016)
Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies
Rafael G. dos Santos et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2016)
The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
Rainer Kraehenmann et al.
NEUROIMAGE-CLINICAL (2016)
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2016)
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA
Michael C. Mithoefer et al.
LANCET PSYCHIATRY (2016)
Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans
Amanda A. Nunes et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
Serotonergic Psychedelics Temporarily Modify Information Transfer in Humans
Joan Francesc Alonso et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flavia de L. Osorio et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2015)
Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study
Jordi Riba et al.
DRUG TESTING AND ANALYSIS (2015)
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Peter Gasser et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
Fernanda Palhano-Fontes et al.
PLOS ONE (2015)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Harvey A. Whiteford et al.
LANCET (2013)
Innovative solutions to novel drug development in mental health
T. R. Insel et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users
Jose Carlos Bouso et al.
PSYCHOPHARMACOLOGY (2013)
Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
Robin L. Carhart-Harris et al.
SCHIZOPHRENIA BULLETIN (2013)
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
Michael Kometer et al.
BIOLOGICAL PSYCHIATRY (2012)
Health status of ayahuasca users
Paulo Cesar Ribeiro Barbosa et al.
DRUG TESTING AND ANALYSIS (2012)
4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects
Fernando Caudevilla-Galligo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Teri S. Krebs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
Katherine A. MacLean et al.
JOURNAL FOR THE SCIENTIFIC STUDY OF RELIGION (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Methodology in conducting a systematic review of systematic reviews of healthcare interventions
Valerie Smith et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Katherine A. MacLean et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
Erich Studerus et al.
PLOS ONE (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
Manel J. Barbanoj et al.
PSYCHOPHARMACOLOGY (2008)
Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members
R. G. Santos et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
Beverley J. Shea et al.
BMC MEDICAL RESEARCH METHODOLOGY (2007)
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
Robert S. Gable
ADDICTION (2007)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
J Riba et al.
PSYCHOPHARMACOLOGY (2006)
Hallucinogen persisting perception disorder: what do we know after 50 years?
JH Halpern et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
分享论文
